NNC-59-0145

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNNC-59-0145
Drug Alias Nameosteoporosis therapy (ZymoGenetics)osteoporosis therapy (Houghten/Zymogenetics)NNC-59-0203NNC-59-0145
ClassificationSmall molecules
Mechanisms of ActionBone metabolism modulators
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLION bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies4basebio AGxLION bioscience IncZymogenetics Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A